> Bristol-Myers Squibb has earned an FDA warning for its Puerto Rico manufacturing plant. Warning letter
> The WHO has begun a pilot prequalification program using selected APIs for HIV treatments, anti-malarials and anti-tuberculosis products. Article
> ATMI has opened a Chinese manufacturing facility with partner Austar, a Hong Kong-based service provider. ATMI release
> PPD and Bend Research will collaborate on formulation development, analytical testing and clinical supplies manufacturing. PPD release
> Liberia has established a regulatory authority to address counterfeit and substandard drugs. Article
> Unilife has secured funding for construction of its headquarters and manufacturing facility in York, PA. Unilife release
> Recipharm will scale-up the manufacturing of DuoCort's tablets for treatment of Addison's disease. Article
> Lonza is seeing increased capacity utilization in custom manufacturing but says regulatory strictness is creating volatility. Item
> UK contract manufacturer SCM Pharma is set to open its first US office after appointing Thomas Puskar its North American business development manager. SCM release
> A proposal for drugmaker support of an unwanted drug disposal program in San Francisco has drawn industry opposition. Article
> Laureate will manufacture AVEO's AV-201, a monoclonal antibody treatment intended cancer. Laureate release